Advertisement

Topics

Latest "Approves Cardio Revolutionary Diagnostic Heart Device" News Stories

11:16 EST 12th December 2017 | BioPortfolio

Here are the most relevant search results for "Approves Cardio Revolutionary Diagnostic Heart Device" found in our extensive news archives from over 250 global news sources.

More Information about Approves Cardio Revolutionary Diagnostic Heart Device on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Approves Cardio Revolutionary Diagnostic Heart Device for you to read. Along with our medical data and news we also list Approves Cardio Revolutionary Diagnostic Heart Device Clinical Trials, which are updated daily. BioPortfolio also has a large database of Approves Cardio Revolutionary Diagnostic Heart Device Companies for you to search.

Showing "Approves Cardio Revolutionary Diagnostic Heart Device" News Articles 1–25 of 12,000+

Tuesday 12th December 2017

Ceres Nanosciences Announces Plans for Significant Growth in Prince William County, Virginia

Ceres Nanosciences (Ceres) is pleased to announce its recent expansion in Prince William County, Virginia. Following a successful fundraising round in 2017, Ceres has rapidly expanded both its staff and its facilities to accommodate the growing demand for the novel Nanotrap® particle platform across the life sciences industry. The Nanotrap® particle prov...


InventHelp Inventor Develops Device to Provide Easier Access to Toilet Paper

InventHelp, a leading inventor service company, is working to submit Compact Bath Tissue Extender to companies for their review. PITTSBURGH, PA (PRWEB) December 12, 2017 Due to his own experience, an inventor from Lake Hopatcong, N.J., knows the difficulty of doing many daily activities due to physical limitations. One of these activities is accessing toilet paper after going to the bathroom. &qu...

Aldevron to Provide New GMP Cas9 Nuclease Through Agreement with Integrated DNA Technologies

Aldevron, a provider of contract plasmid DNA manufacturing, protein production and antibody discovery services, and Integrated DNA Technologies, Inc. (IDT), a supplier of custom nucleic acid and genome editing products, today announced a license agreement whereby Aldevron will manufacture and distribute a S. pyogenes Cas9 variant—known as SpyFi™ Cas9 N...


Bryan Health Releases Compendium of Best Practices in Rural Hospital-Community Partnerships

Case Studies Highlight Collaboration as Key Component to Improving Health Outcomes Bryan Health, a Nebraska-governed nonprofit health system, recently released its 2017 Compendium of Best Practices in Rural Health Hospital-Community Partnerships. The 12 case studies tell the stories of rural Nebraska hospitals partnering with

Global Spirometer Market Analysis 20112017 and Forecast 20182023 [Report Updated: 28112017] Prices from USD $2980

SnapshotA spirometer is a device that gauges lung function by measuring the amount of air a patient is able to blow out of his lungs. A primary care physician or allergist may perform spirometry on a patient if he presents symptoms such as trouble breathing, wheezing, chest tightness or shortness of breath.The global Spirometer market will reach xxx Million USD in 2017 and CAGR xx% 20112017. The r...

Advances in Mobile Device and Computer Vision Prime Wound Care for the Digital Revolution

Utilizing the latest developments in the iOS platform, eKare to expand product lineup to deliver 3D wound imaging on iPhone X. FAIRFAX, Va. (PRWEB) December 12, 2017 eKare Inc., a technology company specializing in advanced imaging for wound care, expands its product lineup to include the newest advances in iOS platform. The inSight® 2.0 for iOS will combine iPhone X’s built-in optics with...

CertaDose Wins Johnson & Johnson Innovation Award for Advancing Safety in Healthcare

Company’s color-coded pediatric syringe could significantly reduce critical dosing errors in children One of the most common mistakes made in emergency rooms is giving children the wrong dose of medicine. Emerging medical device start-up CertaDoseTM, Inc. was recognized by Johnson & Johnson Innovation LLC as having a potential solution for this p...

Health Dialog Achieves 15 Consecutive Years of NCQA Accreditation for Disease Management Programs

Disease management programs meet rigorous standards for patient care and continuous quality improvement Health Dialog, a leading provider of integrated population health management solutions for health plans, risk-bearing providers and self-insured employers, announced today that it has received Patient Oriented Accreditation from the National Committe...

Distributed Bio, Inc. and Pandion Therapeutics, Inc. Announce Multi-Target Collaboration

Distributed Bio, the global leader in computational optimization of fully human monoclonal antibody libraries, today announced a multi-target partnership with Pandion Therapeutics Inc. Distributed Bio will use its proprietary SuperHuman antibody library platform to discover therapeutic ready pre-optimized antibodies against multiple Pandion targets. Pandio...

Agendia: Key Studies Presented at the San Antonio Breast Cancer Symposium Demonstrate the Important Role of MammaPrint® for Patient Pre-Selection, Cost-Effectiveness and For Younger Patients

Data from the I-SPY 2 trial showed the first long-term survival results for patients pre-selected as MammaPrint high-risk, with 94% of the patients who achieved pathological complete response event-free at three years MammaPrint assessment is cost effective in clinical high risk patients compared to clinical risk assessment ...

FDA approves Admelog, the first follow-on insulin product to treat diabetes

The FDA has approved Admelog, a short-acting insulin indicated to improve control in blood

FDA approves Sanofi’s short-acting insulin as ‘follow on’ treatment for diabetes

The US Food and Drug Administration (FDA) has approved Sanofi’s short-acting insulin (Admelog — insulin lispro injection) as a ‘follow on’ product to treat diabetes.

Drawbridge Health and Thorne Research Announce Partnership

Strategic Collaboration Agreement is Aimed to Broaden the Availability and Access to Wellness Testing Drawbridge Health and Thorne Research announced today a strategic collaboration to enable wellness testing, anytime and anywhere, in the health and wellness market. The strategic collaboration will provide Thorne Research and its subsidiary WellnessFX ...

Alnylam Completes Submission of New Drug Application to U.S. Food and Drug Administration (FDA) for Patisiran for the Treatment of Hereditary ATTR (hATTR) Amyloidosis

– Patisiran Could Become the First in a New Class of Medicines Known as RNAi Therapeutics – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today the completion of the rolling submission of a New

Co-Diagnostics, Inc. Announces Sale of Molecular Diagnostic Tests, Including Zika Virus, to Major Caribbean Laboratory

Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostics, announced today that a major laboratory in the Caribbean Basin has completed its first purchase of the Company’s tests. The purchasing laboratory is one of the most recognized in the country, wit...

IDEX Health & Science Announces Acquisition of New Microfluidics Company

Rohnert Park, CA, December 11, 2017 — IDEX Health & Science, LLC  today announced the acquisition of thinXXS Microtechnology that will accelerate growth of its microfluidics consumables business. Located in Zweibrücken, Germany, thinXXS  Microtechnology is a leader in the development and production of plastic microfluidic consumables serving the Life Sciences, Point o...

FierceMedTech ernennt Endotronix zu einem seiner „Fierce 15 Medizintechnikunternehmen des ...

„Wir fühlen uns geehrt, als Fierce 15 Unternehmen ausgewählt worden zu sein. Dies spiegelt das immense Potenzial des Cordella Heart Failure Systems [Herzinsuffizienzsystems] wider, einen Read more...

St. Mary's Hospital Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 28112017] Prices from USD $250

SummarySt. Mary's Hospital St. Mary's, a subsidiary of MedStar Health is a healthcare service provider that offers inpatient and outpatient treatment and diagnostic services. The hospital's services include cardiac, emergency services, family birth, geriatric, neuroscience, oncology, orthopedics, palliative care, pediatrics, psychiatry, dialysis, surgical services, rehab and laboratory services. S...

FDA Approves Admelog, The First Short-Acting 'Follow-on' Insulin Product To Treat Diabetes

NewsAdmelog is a short-acting insulin product indicated to improve control in blood sugar levels in adults and pediatric patients aged 3 years and older with type 1 diabetes mellitus and adults with type 2 diabetes mellitus.

Saranas Named Finalist for Prestigious International Cardiovascular Innovation Award

Saranas, a medical device company with a new technology for real-time detection and monitoring of internal bleeding during endovascular procedures, today announced the company was named as one of the Top 4 Innovators at the International Conference for Innovations in Cardiovascular Systems (ICI) in Tel Aviv, Israel. The ICI Innovation Award is one...

Scotland approves NHS funding for Ibrance, Cerdelga and Invicorp

The latest batch of decisions by the Scottish Medicines Consortium has given patients with certain forms of breast cancer, Gaucher disease and erectile dysfunction new treatment options on the NHS.

FDA approves Sanofi's follow-on version of Lilly’s Humalog

French pharma firm hopes Admelog will make a significant commercial impact in 2018

FDA approves first short-acting, follow-on biologic of Lilly's Humalog insulin product

The FDA has announced its approval of Sanofi’s Admelog (insulin lispro), the first follow-on biologic version of Eli Lilly’s Humalog – a short-acting insulin authorised for the improvement of glycaemic control in in adults and children aged three years and older with type 1 diabetes and adults with type 2 diabetes. The data which prompted the decision was derived from two Phase 3 trials comp...

Microbiome MDx specialist Genetic Analysis signs supply & distribution agreement with Bio-Rad for GA-Map™

Dysbiosis success triggers further investment and development agreement for additional microbiome tests beyond GA-map™ dysbiosis Test (Oslo and Hercules, Calif., 12 December 2017) Genetic Analysis (GA) and Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products, today announced that they have signed a supply and distribution agreement for ...

Edwards Adds To Wide Range Of Approaches To Mitral Repair

Harpoon is a minimally invasive surgery device that complements Edwards pipeline of transcatheter mitral and septal valve repair and replacement...   


Quick Search
Advertisement
 

News Quicklinks